35
Artificial Intelligence Enables Clinical Transformation

Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Artificial Intelligence Enables Clinical Transformation

Page 3: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve
Page 4: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve
Page 5: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Technology Has Reached a Point Where Change Is Possible

What’s happened?

What’s going to happen?

What should we do about it?

Page 6: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Big Data and Machine Learning in the Cloud

Teradata

Care Management

Cloud IngestionMetadata Catalog Security

AI & Machine Learning

Page 7: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Data-Driven Innovation

Integrated data sources for analysis (claims, pharmacy benefits, labs, social determinants of health, EMR, real-time ADT)

Data-driven Population Health strategies(using advanced datasets Blue Cross has deployed clinical programs to chronic condition management)

Predictive models (risk of hospitalization, readmission, emergency department visit)

High-touch clinical engagement (driven by artificial intelligence and advanced data sets)

Rigorous outcomes evaluation(what works, what to scale)

AI

Page 8: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Clinical Analytics Challenge

Page 9: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Framework for Assessing Value

Population Segmentation Model

Select segment(s)to address

Hypothesize root cause(s)

Playbook of known successes

New interventions (internal and external) to address root cause

Decide on “Plays” to run

Run play and monitor results

Playbook

Select lead, population, timing, success metrics

and control group

Success metric achieved

Success metric not achieved

Bring to scale

Add to Playbook

Pull from playbook as

needed

Identify problems to solve

Page 10: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

• Long-Term Effect of Disease Management Program

• Diabetes Prevention Program — Prediabetes Intervention

• Quantitative Financial Analysis of Ochsner Digital Hypertension Program

• Office of Group Benefits Obesity Prevalence and Healthcare Utilization Pattern

• Zero Dollar Copay 2.1 Program Evaluation Expansion

• High-Cost Intervention Program Evaluation

• Pharmacy Carve-in/Carve-out Analysis

• Impact of High-Deductible Benefits on Member Long Term Health Outcomes

• Relationship of PCP Visit Cost-Sharing and Future Healthcare Expenditure

• Low-Value (Wasteful) Service Utilizer Impact on Member Future Healthcare Spend

• Bariatric Surgery Impact on Patient Future Healthcare Cost and Health Outcome

• Quality Blue Value Partnership Program Effectiveness on Lowering Member Total Cost of Care

• Quality Blue Primary Care Program Evaluation

• “Soundbites” Nurse Effectiveness on Improving Patient Engagement

• JIVA Nurse Notes – Using Natural Language Processing

• Near Real-Time Readmission Predictive Model –Using Authorization and ADT data feed

• Machine Learning of Medicare Advantage Medication Adherence Compliance Profile and Prediction

• First Trimester High-Risk Pregnancy Identification and Prediction

Quality, Cost Initiatives

Page 11: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Reduce Financial BarriersZero Dollar Copay, an incentive-based medication program

• Includes members within Blue Cross Disease Management program, with Blue Cross pharmacy benefit manager and have copay plan

• 110+ drugs from 34 therapeutic classes covering: DiabetesHeart diseaseHypertensionLung conditions (e.g. asthma)Mental health conditions

• Offers $0 copays for generic drugs

Page 12: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

12

Increasing Medication AdherencePortion Days Covered (PDC) of Top Prescribed Medications

Page 13: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

13

Zero Dollar Copay Disease Management ProgramReducing Healthcare Use and Costs

Healthcare Utilization Per 1,000 Members

Per Member Per Month (PMPM) Expenditures

Page 14: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

• Members in the program had improved adherence rate compared to control group

• Members in low-income class improved more in medication adherence

• Scaled to 40,000 members; up to 72,000 in July

Net savings: -$72 + $41 = -$31 total PMPM-$372 total PMPY

Rx PMPM: +$41

Medical PMPM: -$72

Zero Dollar Copay: Program Results

Page 15: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Clinical Data Exchange Framework

Member EligibilityChecking

MSG or RecordStructure Edit

CDA

ADT MSG

Vendor Files

FHIR MSG

Data Normalization

Enterprise Master Patient Index

Enterprise Data Governance, Privacy & Security

Eligibility Product

Longitudinal Member Record

Claims

Field Edit

EDW_CDR

Data Lake

Enterprise Data Warehouse

Bulk Message Storage

ProviderNotification

Member & ProviderPortals

Analytics & Reporting

Provider

Terminology Mapping

ADT LAB

Blue Advantage

Commercial Clinical

Lab Files

DuplicateChecking In

tern

al C

onsu

mpt

ion

Data Formats

HL7 ORU

HL7 ADT

HL7 CCDA

HL7 FHIR

Custom

External Partnerships

Data Quality

Clinical Partnerships

Utilization MGMT

Advanced AnalyticsAP

I

Care MGMT

Page 16: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Keys to Success Data quality

Data diversity

Low latency

Call to action

Business integration

Lots of variables

Outcomes evaluation

Diverse AI algorithms

Scalable infra-

structure

Process redesign

Page 17: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Predictive Models Driving Clinical OutcomesRisk of

Hospitalization (ROH)

Risk of Emergency

Department Visit (ROE)

Risk of Readmission

Prediction of High-Cost Claimants

Customer Service

Complaints

Description Hospitalization in the next 6 months

Emergency department visit in the next 6 months

Readmission in the next 1 month

Future high-cost pool ($50,000+) in the next 12 months

Complaint to Customer Servicein next 1 month

Results

1.5x more likely to predict an unplanned admission than commercial model in high-risk group

1.35x more likely to predict emergency department visit than commercial model in high-risk group

Matching a daily authorizations-derived hospital census file with riskscore to notifyproviders

Top 1% generate 17% of cost

Between 200 and 350 members identified as high risk each week

PPV in High Risk Group(Top 1,000)

48% 75% 45% 75% 70%

Page 18: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Blue Cross’ Risk of Hospitalization (ROH) Outperforms Best Commercial Models

Important Predictors• Inpatient hospitalizations in last 2 years• Radiology services in recent 6 months• Ambulance services in recent 6 months• Cardiovascular procedures in recent year• Diabetes episode in last 2 years• # of members in family unit

High-Risk Segment Profiles• Rural parishes: East Carroll, Union,

Vernon, Washington• Low-income blocks

Average Cost perAdmission$15,000

# Members w/ Admit900

ROH PPV45%

Referred Annually2,000

X

Potential Impactable Cost

$13.5 Million=

=

X

Page 19: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Risk of Readmission• Event-level risk score runs Monday through Friday• Key predictors: admit diagnosis, discharge diagnosis, length of stay, service type, discharge

disposition, general risk score

Model re-calibrated for better performance

High Risk3.8% of total dischargesPPV 29.5 %

Medium Risk30.4% of total

dischargesPPV 15.6%

Low Risk65.8% of total discharges

PPV 5.2%

30-day readmission rate was 9.25% during study period

Page 20: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Blue Cross’ Customer Service Model Results

• Intention to Treat analysis was performed with logistic regression (Odds ratio 0.36, p value<0.05)

• 4,500 members identified as high risk

0Complaints after two-week mark when members receive outreach

64% Members who

are reached are 64% less likely to

complain than control

3xRate that control

group complained more than

treatment group

Page 21: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Two predictive models used to manage clinical needs of large commercial groupAn aggressive campaign using artificial intelligence and innovative clinical approaches to better support and manage the group’s members with three chronic conditions was deployed in late 2017

CAD

CHF

Diabetes

• Historically, this group has 19% of its members enrolled in Care Management programs related to these conditions

• Models were used to identify members with the highest opportunity for change; they focused on a much more refined 0.4% of the population

Predictive Models in Action: A Case Study

Page 22: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

About 1% of the population referred to Care Management through Risk of Hospitalizationand Risk of EmergencyDepartment Visit models

18-month referral period

Engagement rate 4x better

Successfully Reduced Adverse Events

1,013

983

Pre 12 months Post 12 months

Number of AdmissionsEngaged Members

30

Calculation: (Admits/member month)*12 months*Members

288

246

Pre 6 months Post 6 months

Number of ED VisitsEngaged Members

42

Calculation: (ER Visits/member month)*6 months*Members

Page 23: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Real-Time Actionable Data

ADT (Admit, Discharge, Transmissions) and Re-Admission feeds are transmitting critical patient demographic information in real time.

• Helps providers stay on top of daily hospital utilizations • Helps providers see which patients are admitted/discharged from a facility• Occurs within 24 hours of the event

Blue Cross Care Management teams now can reach out to these patients via phone to monitor post-discharge behaviors and make sure members schedule follow-up office visits as needed

Page 24: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Enhanced Disease Management• Blue Cross offers state-of-the-art baseline Disease Management services,

plus enhanced services

• Programs focus on members with or at risk for certain chronic diseases

o Focuses on improving health outcomes for members with chronic conditionso Covers heart disease, chronic kidney disease, diabetes, respiratory (COPD and asthma)o Facilitated by Blue Cross nurses via telephone and community-based

• All programs have validated clinical outcomes and cost savings

Page 25: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Program Results: Financial Impacts

-$76

$74

-$150In Program Not in Program DiD

Average Medical PMPM Trends*

*Based on 36-month study of Blue Cross Disease Management program

In Program Not in Program DiD

*Based on 36-month study of Blue Cross Disease Management program

Page 26: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Enhanced Disease Management ResultsProgram Effects on Healthcare Utilization

Members in Blue Cross program:

3.32% fewer emergency department visits

1.53% fewer inpatient admissions

2.13% shorter length of inpatient stays

1.19% more prescriptions

Controlled HbA1c and blood pressure

FewerED visits

Fewerinpatient

admissions/admit days

ControlledHbA1c and

blood pressure

Moreprescriptions

Page 27: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

• Medical PMPM trend differently depending on participation in program• Timing of separation points of the trend may reflect general acuity of

condition and its responsiveness to engagement.

Shorter time of response

Significant deterioration

CHD/Hypertension

Longer time of response

Diabetes

Diabetes and CHD/Hypertension Programs

Page 28: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

• HbA1c showed increasing trend for those not in diabetes program

• CHD/Hypertension program participants had slightly decreasing trend in Systolic BP values

Clinical Outcomes by Participation

HbA1c

Systolic BP

Page 29: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Our In-House Clinical Team• 200+ clinical professionals:

doctors, nurses, dietitians, social workers, pharmacists

• Provide health coaching and support to members dealing with serious illnesses, chronic conditions or acute injuries

• Identify and close gaps in care, coordinate services

• Guide care transformation with providers in our Quality Blue programs

Page 30: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Community Nurse Program • Successful pilot over past two years• Works with designated healthcare

providers in a regional market• Engages members face-to-face using

AI and real-time data • Helps meet high-risk members’

needs, coordinate care, lower risks of readmission

• Improves health outcomes and helps to lower costs

Page 31: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Community Nurse Program: Results

Better engagement, better health outcomes

3.26 times higher engagement with community nurses vs. telephonic nurses only

Model now expanding to other areas in state

14.7%

62.6%

47.9%

Telephonic Nurse Community Nurse Difference

Member Engagement Rate by Outreach

Page 32: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Impactability Over RiskEvaluating which members will benefit the most from which interventions

Member A

Enroll in Care Management and offer six weeks of meal assistance

Engage via mail or email

Risk score

Impactability scorePlan action

High

Low

High

• Chronic kidney disease

• Low credit score

• Has called plan call center• Four family members• Age <80• 4 gaps in care

• On dialysis• In hospice care• Age >80• 0 gaps in careMember B

Page 33: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Key Takeaways• We discover, validate and scale interventions to improve and maintain the health

of those who would otherwise not seek care but who are at risk for deteriorating health or adverse events.

• Drive effective coordination, based on actionable data insights, internally between the Blue Cross care team and clinical team and externally with primary care physicians, specialists and facilities to enhance patient clinical outcomes and lower the total cost of care.

• To create effective programs, AI/ML-based targeting must be combined with robust outcomes evaluation.

• Compare models to industry benchmarks and standards to continually improve performance.

Page 34: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Research• Journal of Medical Economics• American Journal of Managed Care• Value in Health (ISPOR 2018 and 2019)• CDAO Exchange, August 2019• AHIP Institute and Expo, June 2019• Blue Cross and Blue Shield Association

National Summit, May 2019

Page 35: Artificial Intelligence Enables Clinical Transformation · • Zero Dollar Copay 2.1 Program Evaluation Expansion • High-Cost Intervention Program Evaluation • Pharmacy Carve

Somesh Nigam, Ph.D.Chief Analytics and Data Officer

[email protected]